These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23436559)

  • 21. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single String Technique for Coronary Bifurcation Stenting: Detailed Technical Evaluation and Feasibility Analysis.
    G Toth G; Pyxaras S; Mortier P; De Vroey F; Di Gioia G; Adjedj J; Pellicano M; Ferrara A; De Schryver T; Van Hoorebeke L; Verhegghe B; Barbato E; De Bruyne B; De Beule M; Wijns W
    JACC Cardiovasc Interv; 2015 Jun; 8(7):949-59. PubMed ID: 26003016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of balloon inflation for optimal stent deployment: five seconds is not enough.
    Hovasse T; Mylotte D; Garot P; Salvatella N; Morice MC; Chevalier B; Pichard A; Lefèvre T
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):446-53. PubMed ID: 22109977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strut apposition after coronary stent implantation visualised with optical coherence tomography.
    Radu M; Jørgensen E; Kelbaek H; Helqvist S; Skovgaard L; Saunamäki K
    EuroIntervention; 2010 May; 6(1):86-93. PubMed ID: 20542802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of luminal patency of the self-expanding Sideguard sidebranch stent: evaluation by intravascular ultrasound and optical coherence tomography.
    Ma S; Maehara A; Hauptmann KE; Guagliumi G; Valsecchi O; Vassileva AN; Appelman Y; Sangiorgi G; Prati F; Mintz GS
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):734-41. PubMed ID: 24948549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Analysis of Sequential Proximal Optimizing Technique Versus Kissing Balloon Inflation Technique in Provisional Bifurcation Stenting: Fractal Coronary Bifurcation Bench Test.
    Finet G; Derimay F; Motreff P; Guerin P; Pilet P; Ohayon J; Darremont O; Rioufol G
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1308-1317. PubMed ID: 26315733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
    Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
    Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra- and interobserver reliability and intra-catheter reproducibility using frequency domain optical coherence tomography for the evaluation of morphometric stent parameters and qualitative assessment of stent strut coverage.
    Antonsen L; Thayssen P; Junker A; Veien KT; Hansen HS; Hansen KN; Hougaard M; Jensen LO
    Cardiovasc Revasc Med; 2015 Dec; 16(8):469-77. PubMed ID: 26475731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis.
    Alfonso F; Dutary J; Paulo M; Gonzalo N; Pérez-Vizcayno MJ; Jiménez-Quevedo P; Escaned J; Bañuelos C; Hernández R; Macaya C
    Heart; 2012 Aug; 98(16):1213-20. PubMed ID: 22826559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
    Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
    Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel and quick coronary image analysis by instant stent-accentuated three-dimensional optical coherence tomography system in catheterization laboratory.
    Nakao F; Ueda T; Nishimura S; Uchinoumi H; Kanemoto M; Tanaka N; Fujii T
    Cardiovasc Interv Ther; 2013 Jul; 28(3):235-41. PubMed ID: 23355032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography.
    Won H; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):263-70. PubMed ID: 24221904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical coherence tomography for guidance in bifurcation lesion treatment.
    Di Mario C; Iakovou I; van der Giessen WJ; Foin N; Adrianssens T; Tyczynski P; Ghilencea L; Viceconte N; Lindsay AC
    EuroIntervention; 2010 Dec; 6 Suppl J():J99-J106. PubMed ID: 21930500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanical abnormalities associated with first- and second-generation drug-eluting stent thrombosis analyzed by optical coherence tomography in the national PESTO French registry.
    Amabile N; Trouillet C; Meneveau N; Tissot CM; Belle L; Combaret N; Range G; Pansieri M; Delaunay R; Levesque S; Lhermusier T; Derimay F; Motreff P; Caussin C; Souteyrand G
    Int J Cardiol; 2017 Jan; 227():161-165. PubMed ID: 27863292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
    Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
    EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.